JPRN-UMIN000004295已完成2 期
A Multi-center Phase II Clinical trial of 3rd and more line TS-1 treatment for Advanced NSCLC - A Multi-center Phase II Clinical trial of 3rd and more line TS-1 treatment for Advanced NSCLC
Ehime University Graduate School of Medicine0 个研究点目标入组 45 人开始时间: 2010年9月30日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients with serious infections or susupected infections with fever 2)complication of massive pericardial effusion, ascites or pleural sffusion 3)uncontrollable heart failure or Interstitial pneumonitis 4)Pregnant or lactating woman 5)Symptomatic brain metastasis 6)Hystory of active double cancer 7)poorly controled diabetes mellitus 8)Patients whose participation in the trial is judged to be inappropriate by the attending doctor.
研究者
相似试验
进行中（未招募）
1 期
A multi-centre 3-arm randomized phase II trial of BIBF 1120 versus BIBW 2992 versus sequential administration of BIBF 1120 and BIBW 2992 in patients with hormone-resistant prostate cancerChemo-naive hormone refractory prostate cancerEUCTR2005-005249-21-GBBoehringer Ingelheim Ltd.105
进行中（未招募）
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-ATDr. F. Köhler Chemie GmbH40
进行中（未招募）
1 期
Phase 2/3 Clinical Trial with Sodium Thiosulfate for the Treatment of CalciphylaxisCalciphylaxisMedDRA version: 20.0Level: PTClassification code 10051714Term: CalciphylaxisSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2014-002128-28-DEDr. F. Köhler Chemie GmbH40
已完成
2 期
A clinical trial with Sodium Thiosulfate for the treatment of CalciphylaxisCalciphylaxisCirculatory SystemISRCTN73380053Dr. F. Köhler Chemie GmbH (Germany)5
已完成
2 期
Heterologus Prime-Boost Combination of SARS-CoV-2 VaccinesCTRI/2021/08/035993Bharat Biotech International Limited608